Successes
In re USA Technologies, Inc. Sec. Litig., No. 19-cv-4565-JHS
The Rosen Law Firm was sole lead counsel in this consolidated class action in U.S. District Court for the Eastern District of Pennsylvania. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act and §§11b and 15 of the Securities Act arising out of the Company’s issuance of materially false and financial statements. The parties settled the action for $15.3 million in cash.
Christine Asia Co Ltd. v. Alibaba Group Holding Ltd., No. 15-md-2631 (CM) (SDA)
The Rosen Law Firm was sole Class Counsel in this multidistrict certified class action in U.S. District Court for the Southern District of New York. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act arising out of the Company’s issuance of materially false and misleading business information. The parties settled this action for $250 million in cash.
In re Stemline Therapeutics, Inc. Securities Litigation, 17-cv-832 (PAC)
The Rosen Law Firm was co-Lead Counsel in this class action in the U.S. District Court for the Southern District of New York. Following the dismissal of the action and while on appeal with the U.S. Court of Appeals for the Second Circuit, the parties settled this action for $625,000 in cash.
Kelsey v. Textura Corporation, No. 14 C 7837
The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for Northern District of Illinois. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act arising out allegations that the Company misstated its true financial condition. The parties settled this action for $3.3 million in cash.
Katz v. China Century Dragon Media, Inc., No. CV 11-02769 JAK (SSx)
The Rosen Law Firm is currently serving as sole Lead Counsel in this class action pending in the U.S. District Court for the Central District of California. The complaint alleges violations of §§ 11, 12(a)(2), and 15 of the Securities Act of 1933 and §§10b and 20(a) of the Securities Exchange Act arising out of the Company’s issuance of materially false and misleading financial statements. Following entry of default against the issuer and certification of the class, the non-issuer defendants and Plaintiffs have preliminarily agreed to resolve the claims against the non-issuer defendants for $778,333.33, subject to court approval.
In re Flight Safety Technologies, Inc. Securities Litigation, No. 3:04-cv-1175
The Rosen Law Firm was sole Lead Counsel in this consolidated class action in the U.S. District Court for the District of Connecticut. The action alleged violations of §§ 10b and 20(a) of the Securities Exchange Act arising out of the defendants alleged failure to disclose material adverse information concerning the Company’s products under development and misrepresenting the amount of time it would take to commercialize the products. Plaintiffs settled the case for a $1.2 million cash payment to class members.
Balon v. Agria, Inc., No. 16-8376 (SDW)
The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for the District of New Jersey. The complaint alleged violation of §10b and 20(a) of the Securities Exchange Act out of the Company’s manipulation of its stock price. The parties settled this case for $1.3 million in cash.
Sood v. Catalyst Pharmaceutical Partners, Inc., No. 13-CV-23878-UU
The Rosen Law Firm was sole lead counsel in this class action filed in the U.S. District Court for the Southern District of Florida. The complaint alleged that the Company failed to disclose material facts about its primary drug candidate. The parties agreed to settle this action for $3.5 million in cash.
Teague v. Alternate Energy Holdings, Inc., No. 10-CV-634-BLW
The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for the District of Idaho. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act arising out of the Company’s issuance of materially false and misleading financial statements and business condition. The parties settled this action for $450,000.
Hrasok v. Kraton Corporation, No. 18-CV-591
The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for the Southern District of Texas. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act arising out of the company’s issuance of materially false and misleading business information. The parties agreed to settle this action for $1.5 million in cash.
Tapia-Matos v. Caesarstone Sdot-Yam Ltd., No. 15-CV-6726 (JMF)
The Rosen Law Firm was co-Lead Counsel in this class action in the U.S. District Court for Southern District of New York. The complaint alleged violations of §§10b and 20(a) of the Securities Exchange Act arising out of the Company’s issuance of materially false and misleading statements about the Company’s true financial condition and business prospects. The parties agreed to settle this action for $2.2 million in cash.
Chanticleer Holdings, Inc., No. 12-CV-81123-JIC
The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for the Southern District of Florida. The complaint alleged violations of the Securities Act of 1933 in connection with material misrepresentations in the Company’s Registration Statement and Prospectus issued for the Company’s public offering of common stock and warrants. The parties have agreed to settle this action for $850,000 in cash.
In re Nature’s Sunshine Products, Inc. Securities Litigation, No. 2:06-cv-00267-TS-SA
The Rosen Law Firm was sole Lead Class Counsel in this class action in the U.S. District Court for the District of Utah. The complaint alleged violations of §§ 10b and 20(a) of the Securities Exchange Act arising out of the Company’s materially false and misleading statements concerning its financial statements and business practices. Following the certification of the class and extensive discovery, Plaintiffs agreed to settle this case for $6 million in cash.
In re comScore, Inc. Virginia Shareholder Derivative Litigation, No. CL-2016-9465
The Rosen Law Firm was co-lead counsel in this shareholder derivative action in the Virginia state court. The firm helped secure a global settlement of this action and a related federal derivative action consisting of a $10 million cash payment to comScore along with extensive corporate governance reforms.
Ding v. Roka Bioscience, Inc., No. 14-8020 (FLW)
The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for District of New Jersey. The complaint alleges violations of §§11 and 15 of the Securities Act arising out of the Company’s issuance of materially false and misleading business information. The parties agreed to settle this case for $3.275 million in cash.